drugset / Trial / NCT06664125
Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia
RandomizedParallel-groupOpen-labelTreatment
Summary
A Phase 2a, Multicenter, Randomized, Open-label, Active Drug-controlled Trial to Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia
Timeline
- Start
- 2024-12-30
- Primary completion
- 2025-06-30
- Completion
- 2025-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMKX003002 | Unknown | — | Oral |
| Comparator | sevelamer | Other / unclassified | — | Oral |